» Articles » PMID: 36243997

Efficacy of Non-surgical Periodontal Treatment on Patients with Coronary Artery Disease: a Meta-analysis of Randomized Controlled Trials

Overview
Specialty Dentistry
Date 2022 Oct 16
PMID 36243997
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Coronary artery disease (CAD) is defined as one of the most common cardiovascular diseases (CVDs). Periodontitis is one of the risk factors for CAD.

Material And Methods: PubMed, Embase and Cochrane Library databases were carefully and thoroughly retrieved until October 2021. On the basis of the inclusion and exclusion criteria, eligible articles were selected strictly to identify randomized controlled trials (RCTs). Using Cochran's Q statistic, Review Manager 5.4 and Stata 16, data were extracted, and a comprehensive analysis was carried out.

Results: Six RCTs of 619 patients were included in this study, including 360 in the intervention group (IG) and 259 in the control group (CG). Meta-analysis showed significant difference for C-reactive protein (CRP) (1.20mg/L, 95% CI: 1.13 to 1.27, p < 0.00001) after non-surgical periodontal therapy (NSPT), but showed no significant difference for interleukin-6 (IL-6) (1.19mg/L, 95% CI: -1.03 to 3.40, p=0.29), flow-mediated dilation (FMD) (-1.64%, 95% CI: -4.95 to 1.67, p=0.33), triacylglycerol (TG) (-0.02mg/dL, 95% CI: -0.31 to 0.27, p=0.90), total cholesterol (TC) (0.04mg/dL, 95% CI: -0.25 to 0.33, p=0.90), low-density lipoprotein cholesterol (LDL-C) (0.00mg/dL, 95% CI: -0.29 to 0.29, p=0.99) and high-density lipoprotein cholesterol (HDL-C) (0.11mg/dL, 95% CI: -0.18 to 0.40, p=0.46).

Conclusions: The impact of NSPT on the reduction of CRP in patients of CAD with periodontitis is significant. NSPT can be considered as an important preventive strategy for major cardiovascular events in CAD.

Citing Articles

Periodontal disease and cardiovascular disease: umbrella review.

Arbildo-Vega H, Cruzado-Oliva F, Coronel-Zubiate F, Meza-Malaga J, Lujan-Valencia S, Lujan-Urviola E BMC Oral Health. 2024; 24(1):1308.

PMID: 39468505 PMC: 11520879. DOI: 10.1186/s12903-024-04907-1.


2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.

Chao T, Lin T, Cheng C, Wu Y, Ueng K, Wu Y Acta Cardiol Sin. 2024; 40(5):479-543.

PMID: 39308649 PMC: 11413940. DOI: 10.6515/ACS.202409_40(5).20240724A.


Effect of non-surgical periodontal therapy on risk markers of cardiovascular disease: a systematic review and meta-analysis.

Meng R, Xu J, Fan C, Liao H, Wu Z, Zeng Q BMC Oral Health. 2024; 24(1):692.

PMID: 38877442 PMC: 11177403. DOI: 10.1186/s12903-024-04433-0.


Analysis of the Effects of , , and Gene Polymorphisms; IL-6 Levels; and CRP Levels on Chronic Periodontitis in Coronary Artery Disease in Indonesia.

Sitompul S, Pikir B, Aryati , Kencono Wungu C, Supandi S, Sinta M Genes (Basel). 2023; 14(5).

PMID: 37239434 PMC: 10218264. DOI: 10.3390/genes14051073.

References
1.
Desvarieux M, Demmer R, Rundek T, Boden-Albala B, Jacobs Jr D, Sacco R . Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation. 2005; 111(5):576-82. PMC: 2812915. DOI: 10.1161/01.CIR.0000154582.37101.15. View

2.
Kataoka H, Kume N, Miyamoto S, Minami M, Morimoto M, Hayashida K . Oxidized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2001; 21(6):955-60. DOI: 10.1161/01.atv.21.6.955. View

3.
Vasconcelos A, Vasconcelos D, da Silva F, Franca L, Alves E, Lenardo D . Periodontitis causes abnormalities in the liver of rats. J Periodontol. 2018; 90(3):295-305. PMC: 8552593. DOI: 10.1002/JPER.18-0226. View

4.
Lobo M, Schmidt M, Lopes R, Dipp T, Feijo I, Schmidt K . Treating periodontal disease in patients with myocardial infarction: A randomized clinical trial. Eur J Intern Med. 2019; 71:76-80. DOI: 10.1016/j.ejim.2019.08.012. View

5.
Zhang T, Kurita-Ochiai T, Hashizume T, Du Y, Oguchi S, Yamamoto M . Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol Med Microbiol. 2010; 59(2):143-51. DOI: 10.1111/j.1574-695X.2010.00674.x. View